Inactivation of SARS-CoV-2 by Catechins from Green Tea.


Journal

Japanese journal of infectious diseases
ISSN: 1884-2836
Titre abrégé: Jpn J Infect Dis
Pays: Japan
ID NLM: 100893704

Informations de publication

Date de publication:
22 Sep 2021
Historique:
pubmed: 2 2 2021
medline: 2 10 2021
entrez: 1 2 2021
Statut: ppublish

Résumé

Green tea extracts effectively inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro in a dose-dependent manner. Ten-fold serially diluted solutions of catechin mixture reagent from green tea were mixed with the viral culture fluid at a volume ratio of 9:1, respectively, and incubated at room temperature for 5 min. The solution of 10 mg/mL catechin reagent reduced the viral titer by 4.2 log and 1.0 mg/mL solution by one log. Pre-infection treatment of cells with the reagent alone did not affect viral growth. In addition, cells treated with only the reagent were assayed for host cell viability using the WST-8 system, and almost no host cell damage by the treatment was observed. These findings suggested that the direct treatment of virus with the reagent before inoculation decreased the viral activity and that catechins might have the potential to suppress SARSCoV-2 infection.

Identifiants

pubmed: 33518628
doi: 10.7883/yoken.JJID.2020.902
doi:

Substances chimiques

Antiviral Agents 0
Tea 0
Catechin 8R1V1STN48

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

421-423

Auteurs

Hidekazu Nishimura (H)

Virus Research Center, Clinical Research Division, Sendai Medical Center, Japan.

Michiko Okamoto (M)

Department of Virology, Tohoku University Graduate School of Medicine, Japan.

Isolde Dapat (I)

Virus Research Center, Clinical Research Division, Sendai Medical Center, Japan.

Masanori Katsumi (M)

Sendai City Institute for Public Health, Japan.

Hitoshi Oshitani (H)

Department of Virology, Tohoku University Graduate School of Medicine, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH